MEDI.SOLA secures KRW 13 billion Series A funding to officially launch personalized 스피드 바카라 care solution business

[by Kang, In Hyo] MEDI.SOLA, a company specializing in customized 스피드 바카라 care solutions, announced on April 3 that it has successfully secured KRW 13 billion (approximately USD 8.8 million) in Series A funding. Key investors in this round included Premier Partners, Samsung Venture Investment, and Redbadge Pacific. According to the company, the investment reflects a strong evaluation of MEDI.SOLA's technological capabilities and growth potential by the participating investors.

MEDI.SOLA is a 스피드 바카라 tech company founded in December 2021 by CEO Lee Seung-yeon and CEO Lee Don-gu. Lee Seung-yeon, formerly Vice President of S 스피드 바카라, played a key role in establishing and managing retail brands such as 'Johncook Deli Meats,' overseeing marketing, sales, and operations. Lee Don-gu, on the other hand, has extensive experience in the healthcare and biotechnology sectors, having led investment initiatives at KB Investment. In 2024, the company secured around KRW 2 billion in funding through a pre-Series A investment round.

MEDI.SOLA implements a ‘home-cooked-based 스피드 바카라 care’ system, offering two categories: ‘스피드 바카라 Care,’ designed for proactive health maintenance, and ‘Medi 스피드 바카라,’ which provides targeted nutritional support for individuals with specific health concerns. Through this model, the company aims to deliver sustainable health management solutions through 스피드 바카라 as a means of personalized care.

In addition, MEDI.SOLA is expanding beyond conventional healthy diets into the digital healthcare sector through ‘ARCHEN.X’, an AI-based healthcare platform currently under development. This initiative includes improvements in diet design algorithms, the identification of data-driven functional 스피드 바카라 ingredients, and the development of digital diet prescription technologies.

Notably, MEDI.SOLA has been conducting joint clinical intervention research with Severance Hospital for over six years, aiming to validate its solutions’ clinical efficacy in real-world patient settings. Through this research, the company is simultaneously strengthening its technological credibility and academic standing. The studies focus on diverse target groups, including patients with recurrent breast cancer, hyperlipidemia, and chronic kidney disease, and have resulting in the publication of SCI(E)-level papers. By leveraging this medical verification process, the company is establishing a high entry barrier in the dietary intervention market, distinguishing itself from competitors.

With the newly secured investment, MEDI.SOLA aims to accelerate its comprehensive business expansion across multiple areas, including enhancing AI-based diet design algorithms, expanding R&D on customized functional 스피드 바카라s for specific diseases, scaling its 스피드 바카라 care platform through the integration of health data, and accelerating its entry into the B2B and B2C markets.

Co-CEO Lee Seung-yeon, who previously suffered from severe nutritional deficiencies and subsequently began researching the Korean Mediterranean diet in collaboration with medical professionals and clinical nutritionists, stated, “The innovation of dietary habits focused on disease prevention and management through home-based remedies has become an inevitable trend.” Lee further emphasized, “Our goal is to create a future where everyone has equal access to essential nutrition, tailored to the specific dietary needs of Koreans.”

“MEDI.SOLA embodies the philosophy that ‘스피드 바카라 is Medicine’ by leveraging personal health information and nutritional data, with the goal of redefining 스피드 바카라 as a new form of treatment,” Co-CEO Lee Don-gu further highlighted. “With this investment, we aim to propel MEDI.SOLA into a leading global company in the customized 스피드 바카라 care industry.”

The Samsung Venture Investment reviewer who led this funding round remarked, “MEDI.SOLA has successfully integrated technology, data, and medicine, position itself as a ‘next-generation healthcare solution company’ that bridges the gap between 스피드 바카라 and medicine.” The reviewer further expressed, “We anticipate significant market expansion through its platform business and the development of functional 스피드 바카라s in the future.”

MEDI.SOLA aims to contribute to disease prevention and the improvement of quality of life through science-based 스피드 바카라 care solutions that integrate medicine, nutrition, and information technology (IT). Additionally, the company plans to actively expand into the global market and strengthen strategic partnerships to accelerate its growth and impact.